ATE517086T1 - Verfahren zur synthese von 3-amino-1- arylpropylindolen - Google Patents

Verfahren zur synthese von 3-amino-1- arylpropylindolen

Info

Publication number
ATE517086T1
ATE517086T1 AT06819599T AT06819599T ATE517086T1 AT E517086 T1 ATE517086 T1 AT E517086T1 AT 06819599 T AT06819599 T AT 06819599T AT 06819599 T AT06819599 T AT 06819599T AT E517086 T1 ATE517086 T1 AT E517086T1
Authority
AT
Austria
Prior art keywords
arylpropylindoles
synthesis
amino
formula
compound
Prior art date
Application number
AT06819599T
Other languages
English (en)
Inventor
Terrence Joseph Connolly
Robert P Farrell
Eric R Humphreys
Stephen M Lynch
Keshab Sarma
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE517086T1 publication Critical patent/ATE517086T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/4045Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/405Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT06819599T 2005-11-30 2006-11-20 Verfahren zur synthese von 3-amino-1- arylpropylindolen ATE517086T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74151605P 2005-11-30 2005-11-30
PCT/EP2006/068644 WO2007062994A1 (en) 2005-11-30 2006-11-20 Methods for synthesis of 3-amino-1-arylpropyl indoles

Publications (1)

Publication Number Publication Date
ATE517086T1 true ATE517086T1 (de) 2011-08-15

Family

ID=37887751

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06819599T ATE517086T1 (de) 2005-11-30 2006-11-20 Verfahren zur synthese von 3-amino-1- arylpropylindolen

Country Status (11)

Country Link
US (1) US7598399B2 (de)
EP (1) EP1957454B1 (de)
JP (1) JP2009523705A (de)
KR (1) KR20080080593A (de)
CN (1) CN101316819B (de)
AT (1) ATE517086T1 (de)
AU (1) AU2006319229B2 (de)
BR (1) BRPI0619247A2 (de)
CA (1) CA2631048A1 (de)
ES (1) ES2368416T3 (de)
WO (1) WO2007062994A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7632540B2 (en) * 2003-07-01 2009-12-15 Transitions Optical, Inc. Alignment facilities for optical dyes
DE102008030206A1 (de) 2008-06-25 2009-12-31 Bayer Schering Pharma Aktiengesellschaft 3-Cyanoalky- und 3-Hydroxyalkyl-Indole und ihre Verwendung
DE102008030207A1 (de) 2008-06-25 2009-12-31 Bayer Schering Pharma Aktiengesellschaft Substituierte 7-Sulfanylmethyl-, 7-Sulfinylmethyl- und 7-Sulfonylmethyl-Indole und ihre Verwendung
CA2732278C (en) * 2008-07-31 2017-12-19 The Lubrizol Corporation Copolymers and lubricating compositions thereof
CA2774616A1 (en) * 2009-09-23 2011-03-31 Biokier, Inc. Composition and method for treatment of diabetes

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB705652A (en) 1948-10-01 1954-03-17 Farbewerke Hoechst Ag Manufacture of 3-aminopropane compounds
DE849108C (de) 1948-10-01 1952-09-11 Hoechst Ag Verfahren zur Herstellung von 1-disubstituierten 3-Aminopropanen
NL82464C (de) 1952-01-05
US2708197A (en) 1952-05-24 1955-05-10 Upjohn Co Preparation of (hydroxy-3-indole)-alkylamines
US2984670A (en) 1959-05-22 1961-05-16 Upjohn Co Novel 3-(1-hydroxy-1-phenyl-3-aminopropyl) indoles
GB992731A (en) 1962-09-28 1965-05-19 Koninklijke Pharma Fab Nv Aminoalkyl-indolyl-benzyl alcohols
JPH0314562A (ja) 1988-04-11 1991-01-23 Nippon Chemiphar Co Ltd 新規なアルキレンジアミン誘導体およびグルタミン酸遮断剤
EP0600830A1 (de) 1992-11-27 1994-06-08 Ciba-Geigy Ag Substituierte Derivate von Diaminophthalimid als Protein-Tyrosin-Kinase-Hemmer
GB9225141D0 (en) 1992-12-01 1993-01-20 Smithkline Beecham Corp Chemical compounds
US6071970A (en) 1993-02-08 2000-06-06 Nps Pharmaceuticals, Inc. Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
GB9518552D0 (en) 1995-09-11 1995-11-08 Fujisawa Pharmaceutical Co New heterocyclic compounds
GB9523948D0 (en) 1995-11-23 1996-01-24 Univ East Anglia Process for preparing n-benzyl indoles
JP2002511835A (ja) 1996-06-07 2002-04-16 エヌピーエス・ファーマシウティカルズ・インコーポレイテッド 神経障害および神経病の治療に有用な受容体作動性カルシウムチャネル上の新規部位で活性な化合物
SE9701144D0 (sv) 1997-03-27 1997-03-27 Pharmacia & Upjohn Ab Novel compounds, their use and preparation
EP0887348A1 (de) 1997-06-25 1998-12-30 Boehringer Mannheim Italia S.p.A. Bis-Indolderivative mit antimetastatischer Wirkung, Verfahren für deren Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
CA2303830A1 (en) 1997-09-26 1999-04-08 Merck & Co., Inc. Novel angiogenesis inhibitors
WO1999021553A1 (en) 1997-10-28 1999-05-06 Merck & Co., Inc. Antagonists of gonadotropin releasing hormone
EP1049472A4 (de) 1997-10-28 2002-04-03 Merck & Co Inc Antagonisten des gonadotropin freisetzenden hormons
WO2000002551A2 (en) 1998-07-13 2000-01-20 Nps Pharmaceuticals, Inc. Methods and compounds for treating depression
SE9903998D0 (sv) 1999-11-03 1999-11-03 Astra Ab New compounds
FR2814073B1 (fr) 2000-09-21 2005-06-24 Yang Ji Chemical Company Ltd Composition pharmaceutique antifongique et/ou antiparasitaire et nouveaux derives de l'indole a titre de principes actifs d'une telle composition
JP2004523565A (ja) 2001-03-05 2004-08-05 トランス テック ファーマ,インコーポレイテッド 治療因子としてのベンゾイミダゾール誘導体
CN1314673C (zh) * 2002-07-02 2007-05-09 中国科学院上海有机化学研究所 具有手性的多齿噁唑啉配体及其与主族金属或过渡金属的配合物、合成方法及其用途
US7517899B2 (en) 2004-03-30 2009-04-14 Wyeth Phenylaminopropanol derivatives and methods of their use
WO2005118539A1 (en) * 2004-06-01 2005-12-15 F.Hoffmann-La Roche Ag 3-amino-1-arylpropyl indoles as monoamine reuptake inhibitor

Also Published As

Publication number Publication date
US20070135647A1 (en) 2007-06-14
EP1957454B1 (de) 2011-07-20
KR20080080593A (ko) 2008-09-04
AU2006319229A1 (en) 2007-06-07
US7598399B2 (en) 2009-10-06
AU2006319229B2 (en) 2011-09-15
ES2368416T3 (es) 2011-11-17
CN101316819A (zh) 2008-12-03
CN101316819B (zh) 2011-05-18
WO2007062994A1 (en) 2007-06-07
CA2631048A1 (en) 2007-06-07
EP1957454A1 (de) 2008-08-20
JP2009523705A (ja) 2009-06-25
BRPI0619247A2 (pt) 2011-09-20

Similar Documents

Publication Publication Date Title
EA200800321A1 (ru) Ингибиторы гистондеацетилазы
PH12014501033A1 (en) Aryl-and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
EA201070451A1 (ru) Амидные соединения
EA201000883A1 (ru) Производные индолинона и способ их получения
EA201070256A1 (ru) Способ и промежуточные соединения для получения ингибиторов интегразы
UA96961C2 (uk) Азаадамантанові похідні і способи застосування
EA201070912A1 (ru) Производные оксима в качестве ингибиторов hsp90
EA201000642A1 (ru) 2'-фтор-2'-дезокситетрагидроуридины в качестве ингибиторов цитидиндеаминазы
EA200901529A1 (ru) Производные арилоазол-2-илцианоэтиламина, способ их получения и способ их применения
EA201170618A1 (ru) Способ получения защищенных производных l-аланина
EA201100093A1 (ru) Тиадиазолилоксифениламидины и применение их в качестве фунгицидов
ATE539054T1 (de) Verfahren zur herstellung von dihydropyrrolderivaten als zwischenprodukte
EA200970247A1 (ru) Способ получения оптического активного n-защищенного 3-аминопирролидина или оптически активного n-защищенного 3-аминопиперидина и соответствующих кетонов путем оптического разделения рацемических смесей аминов с использованием бактериальной омега-трансаминазы
EA017249B8 (ru) Арил- и гетероарилзамещенные тетрагидробензо-1,4-диазепины и их применение для блокирования обратного захвата норэпинефрина, допамина и серотонина
EA201070467A1 (ru) Способ модификации твердого состояния соединения и соаморфные композиции, полученные этим способом
EA201190293A1 (ru) Пролекарства триптолида
MA32943B1 (fr) Piperidine spiro pyrrolidione et piperidinone substituees, leur preparation et leur utilisation therapeutique
EA200900090A1 (ru) Бензиламины, способ их получения и их применение в качестве противовоспалительных средств
WO2008035212A3 (en) Processes for preparing intermediate compounds useful for the preparation of cinacalcet
ATE448230T1 (de) Für die behandlung von obesitas geeignete tricyclische amidderivate
DK2407451T3 (da) N,N-substituerede 3-aminopyrrolidin-forbindelser anvendelige som monoamin-genoptagelseshæmmere
WO2010011811A3 (en) 3-(phenoxyphenylmethyl)pyrrolidine compounds
MX2009011922A (es) Tetrahidrobenzazepinas ariloxi- y heteroariloxi-sustituidas y uso de las mismas para bloquear reabsorcion de norepinefrina, dopamina y serotonina.
NO20081617L (no) Metoder for fremstilling av Glutaminsyrederivater
WO2009039362A3 (en) Chiral synthesis of diazepinoquinolines

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties